Silverberg JI, Kirsner RS, Margolis DJ, Tharp M, et al. Efficacy and safety of crisaborole ointment, 2%, in participants aged >/=45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study. J Am Acad Dermatol 2024;90:945-952.
PMID: 38340127